Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
23 studies found for:    Pancreas%20Transplant
Show Display Options
Rank Status Study
1 Recruiting Glucose/Insulin Clamp on Solid Organ Transplant (Liver, Kidney, Pancreas and Heart) on Cadaveric Donors
Condition: Complication of Transplanted Organ, Nos
Intervention: Other: Hyperinsulinemic/normoglycemic clamp
2 Recruiting An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets Within the Bioartificial Pancreas Beta-Air in Patients With Type 1 Diabetes Mellitus
Condition: Long-standing Type 1 Diabetes Mellitus
Intervention: Device: Beta-Air device for encapsulation of transplanted human islets
3 Unknown  Diagnostic Accuracy of FNA: is Aspiration- Related?
Intervention: Other: different volume aspiration
4 Enrolling by invitation Remote Ischemic Preconditioning In Abdominal Organ Transplantation
Conditions: Kidney Transplant;   Liver Transplant;   Pancreas Transplant
Intervention: Procedure: Remote Ischemic Preconditioning by Inflation of Pneumatic Tourniquet
5 Completed Prograf-Advagraf Cross Over Conversion Study
Condition: Kidney-Pancreas Transplantation
Intervention: Drug: Tacrolimus
6 Completed LEA29Y (Belatacept) Emory Edmonton Protocol
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: Allogeneic Pancreatic Islet Cells;   Biological: Belatacept;   Biological: Basiliximab;   Drug: Mycophenolate Mofetil;   Drug: Tacrolimus;   Procedure: Intraportal infusion of islet cells
7 Unknown  Hyperinsulinemic Normoglycemic Clamp for Pancreas and Simultaneous Pancreas/Kidney Transplant Recipients
Condition: Postoperative Complications
Intervention: Other: Hyperinsulinemic Normoglycemic Clamp
8 Completed Simultaneous Pancreas-kidney Transplantation With Campath Protocol
Condition: Pancreas-Kidney Transplantation
Interventions: Drug: Alemtuzumab;   Drug: Rabbit Anti-Human Thymocyte Globulin
9 Unknown  Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal Transplant
Conditions: Type 1 Diabetes;   Type 2 Diabetes
Intervention: Biological: Autologous CD34+ stem cells
10 Active, not recruiting Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation
Condition: Graft Rejection
Interventions: Drug: Alemtuzumab;   Drug: Anti-Thymocyte Globulin
11 No longer available B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: Allogeneic Pancreatic Islet Cells;   Drug: Sirolimus;   Biological: Basiliximab;   Drug: Tacrolimus;   Drug: Antibacterial, Antifungal, and Antiviral Prophylaxis;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Clotrimazole;   Drug: Valganciclovir;   Drug: Heparin;   Drug: Enoxaparin;   Drug: Pentoxifylline;   Drug: Aspirin
12 Completed PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus
Condition: Type1 Diabetes Mellitus
Intervention: Drug: 18F-fallypride
13 Terminated
Has Results
Liver Transplantation for Cholangiocarcinoma
Conditions: Cancer;   Cholangiocarcinoma;   Liver
Intervention: Procedure: Liver Transplantation
14 Recruiting Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium
Condition: Transplant; Failure, Kidney
Interventions: Drug: Tacrolimus, Everolimus;   Drug: Tacrolimus, Myfortic
15 Recruiting Bone Marrow Derived Stem Cell Transplantation in T2DM
Condition: Type 2 Diabetes Mellitus
Interventions: Biological: mesenchymal stem cell transplantation;   Other: control;   Biological: MNC's TRANSPLANTATION
16 Completed Effects of Rituximab on the Progression of Type 1 Diabetes in New Onset Subjects
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Anti-CD20 (rituximab)
17 Active, not recruiting Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant
Condition: Renal Transplantation
Interventions: Drug: CsA;   Drug: Belatacept LI;   Drug: Belatacept MI
18 Completed Impact of Microparticles on Postoperative Complications in Surgical Patients
Conditions: Neoplasm, Hepatic;   Pancreatic Neoplasms;   Colorectal Neoplasms
19 Active, not recruiting Cord Blood Infusion for Type 1 Diabetes Mellitus (T1DM)
Conditions: Type 1 Diabetes;   Children
Intervention: Other: Umbilical Cord Blood VITA 34
20 Active, not recruiting Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT)
Conditions: Kidney Transplantation;   Chronic Kidney Failure
Interventions: Drug: CsA;   Drug: Belatacept LI;   Drug: Belatacept MI

   Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results    Last Page
Indicates status has not been verified in more than two years